Scarica l'app Stockscreener
99.70
0.29%
-0.29
Precedente Chiudi:
$99.99
Aprire:
$100.09
Volume 24 ore:
1.71M
Relative Volume:
1.82
Capitalizzazione di mercato:
$6.51B
Reddito:
$1.54B
Utile/perdita netta:
$233.56M
Rapporto P/E:
29.61
EPS:
3.3669
Flusso di cassa netto:
$348.64M
1 W Prestazione:
-0.45%
1M Prestazione:
-0.84%
6M Prestazione:
+18.80%
1 anno Prestazione:
+76.90%
Intervallo 1D:
$99.59
$100.28
Intervallo di 1 settimana:
$99.59
$100.36
Portata 52W:
$50.16
$111.86
Lantheus Holdings Inc Stock (LNTH) Company Profile
Nome
Lantheus Holdings Inc
Settore
Telefono
978 671-8001
Indirizzo
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Compare LNTH vs TAK, TEVA, HLN, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
99.70 | 6.51B | 1.54B | 233.56M | 348.64M | 3.3669 |
TAK
Takeda Pharmaceutical Co Adr
|
19.67 | 62.84B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
41.50 | 48.40B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
10.13 | 44.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
79.38 | 32.80B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
533.12 | 22.87B | 3.17B | 1.29B | 1.01B | 27.09 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-10-13 | Downgrade | Mizuho | Outperform → Neutral |
| 2026-02-26 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2025-12-12 | Aggiornamento | Truist | Hold → Buy |
| 2025-10-08 | Downgrade | Goldman | Buy → Neutral |
| 2025-08-12 | Downgrade | Truist | Buy → Hold |
| 2024-12-18 | Iniziato | Goldman | Buy |
| 2024-09-03 | Iniziato | Redburn Atlantic | Buy |
| 2024-07-10 | Reiterato | JMP Securities | Mkt Outperform |
| 2023-12-18 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-12-04 | Iniziato | TD Cowen | Outperform |
| 2023-09-29 | Iniziato | William Blair | Outperform |
| 2023-03-08 | Iniziato | JMP Securities | Mkt Outperform |
| 2022-11-30 | Iniziato | SVB Leerink | Outperform |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-05-09 | Iniziato | B. Riley Securities | Buy |
| 2022-04-13 | Iniziato | Truist | Buy |
| 2021-02-01 | Iniziato | SVB Leerink | Outperform |
| 2020-06-29 | Ripresa | Jefferies | Buy |
| 2019-08-16 | Aggiornamento | CJS Securities | Market Perform → Market Outperform |
| 2017-11-02 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2016-11-08 | Reiterato | RBC Capital Mkts | Outperform |
| 2016-09-23 | Ripresa | Credit Suisse | Neutral |
| 2016-02-24 | Reiterato | RBC Capital Mkts | Outperform |
| 2015-12-11 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2015-09-30 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2015-07-20 | Iniziato | Credit Suisse | Outperform |
| 2015-07-20 | Iniziato | Jefferies | Buy |
| 2015-07-20 | Iniziato | RBC Capital Mkts | Outperform |
| 2015-07-20 | Iniziato | Robert W. Baird | Outperform |
| 2015-07-20 | Iniziato | Wells Fargo | Outperform |
Mostra tutto
Lantheus Holdings Inc Borsa (LNTH) Ultime notizie
LNTH Downgraded by Mizuho -- Price Target Lowered to $109 - GuruFocus
Technical Reactions to LNTH Trends in Macro Strategies - Stock Traders Daily
Lantheus Holdings, Inc. (LNTH) Stock Forecasts - Yahoo! Finance Canada
Lantheus Holdings stock gets CMS status for PYLARIFY TruVu - AD HOC NEWS
Lantheus Holdings, Inc. (LNTH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Lantheus stock heads toward October 14 merger vote - AD HOC NEWS
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Option Care Health, Inc. (Nasdaq – OPCH), Lantheus Holdings Inc. (Nasdaq – LNTH), MarketAxess Holdings Inc. - StreetInsider
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Option Care Health, Inc. (Nasdaq – OPCH), Lantheus Holdings Inc. (Nasdaq – LNTH), MarketAxess Holdings Inc. (Nasdaq – MKTX), Sangoma Technologies C - The Daily Tribune News
Lantheus Holdings stock faces an October 14 merger vote - AD HOC NEWS
Lantheus Holdings discloses litigation, Morgan Stanley valuation ranges ahead of stockholder vote - TradingView
Lantheus Holdings, Inc. (LNTH) Stock Forecasts - Yahoo! Finance Canada
Halper Sadeh LLC is Investigating Whether ITGR, FHB, INDV, LNTH are Obtaining Fair Deals for their Shareholders - GlobeNewswire Inc.
Starting Oct. 1, Lantheus's prostate cancer scan qualifies for separate Medicare payment in hospital outpatient care. - Stock Titan
Preferred dividends of Lantheus Holdings Inc – HAN:0L8 - TradingView
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: SoundThinking, Inc. (Nasdaq – SSTI), Lantheus Holdings Inc. (Nasdaq – LNTH), MarketAxess Holdings Inc. (Nasdaq – MKTX), Sangoma Technologies Corpor - mykxlg.com
Lantheus Investor Asks Court To Halt 'Unfair' $8B Curium Deal - Law360
Lantheus Investor Asks Court To Halt 'Unfair' $8B Curium Deal - Law360
Lantheus Holdings (LNTH) Could Be 7% Undervalued On BRAVNETSA Approval - Yahoo Finance
Lantheus Holdings (LNTH) Stock May Be 14% Undervalued On FDA Approval - Yahoo Finance
Lantheus Holdings, Inc. (LNTH) Stock Forecasts - Yahoo Finance
Strong Earnings, FDA Approval, and Takeover Interest Drive Lantheus Holdings’ (LNTH) Rally - Yahoo Finance
(LNTH) Risk Channels and Responsive Allocation - Stock Traders Daily
LNTH, ITGR and CZR Deals Face Investor Scrutiny - stl.news
Lantheus Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lantheus Holdings, Inc.LNTH - Business Wire
Perspective Therapeutics (CATX) Insider Sale: 10% Owner Lantheus Alpha Therapy, LLC Sells 247,932 Shares - GuruFocus
Perspective Therapeutics (CATX) holder sells stock near $3.10 - Stock Titan
Lantheus Alpha Therapy Sells 113,914 Perspective Therapeutics (AMEX: CATX) Shares at Up to $3.14 Per Share - Kalkine Media
Lantheus Entities Hold 20.9% Stake in Radiopharm Theranostics (NASDAQ: RADX) Including Significant Options - Kalkine Media
Lantheus Group Reduces Stake in Perspective Therapeutics (AMEX: CATX) to 10% Amid Activist 13D Filing - Kalkine Media
Lantheus Holdings (NASDAQ: LNTH) 10% Stakeholder Alpha Therapy Sells 42,129 Shares at $3.11 Each - Kalkine Media
Lantheus (NASDAQ: LNTH) holders to vote on cash buyout with potential bonus payout - Stock Titan
Radioligand Therapy Market to Grow from USD 2.98 Billion in 2025 to USD 15.85 Billion by 2035, at a CAGR of 18.2%SNS Insider - GlobeNewswire Inc.
Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring Growth Potential in the Healthcare Sector - DirectorsTalk Interviews
Lantheus alpha therapy, CATX director, sells $131k in stock By Investing.com - Investing.com Australia
Lantheus alpha therapy, CATX director, sells $131k in stock By Investing.com - Investing.com South Africa
Lantheus alpha therapy, CATX director, sells $131k in stock - Investing.com
Lantheus alpha therapy, CATX director, sells $131k in stock By Investing.com - Investing.com Canada
Lantheus alpha therapy, CATX director, sells $131k in stock By Investing.com - Investing.com India
Perspective Therapeutics (CATX) Insider Sell: 10% Owner Lantheus Alpha Therapy, LLC Disposes of 42,129 Shares - GuruFocus
Perspective Therapeutics (CATX) backer trims stake but keeps 11.5M shares - Stock Titan
10% owner of Perspective Therapeutics (NYSE: CATX) sells 113,914 shares over two days - Stock Titan
Perspective Therapeutics (CATX) backer Lantheus now owns 10% after share sales - Stock Titan
Lantheus Holdings (NASDAQ: LNTH) Disposes of 35,769 Perspective Therapeutics Shares at $3.12 Each - kalkinemedia.com
Perspective Therapeutics Inc (CATX) Insider Sell: 10% Owner Holdings, Lantheus Disposes of 35,769 Shares - GuruFocus
Perspective Therapeutics (CATX) holder sells 35K shares, still owns 11.6M - Stock Titan
Perspective Therapeutics Inc (CATX) Insider Sell: 10% Owner Holdings, Lantheus Disposes of 78,145 Shares - GuruFocus
Lantheus Holdings sells $245,609 in Perspective Therapeutics stock By Investing.com - Investing.com Nigeria
Lantheus Holdings sells $245,609 in Perspective Therapeutics stock By Investing.com - Investing.com India
Lantheus Holdings sells $245,609 in Perspective Therapeutics stock - Investing.com
Lantheus Holdings sells $245,609 in Perspective Therapeutics stock By Investing.com - Investing.com UK
Lantheus Holdings Inc Azioni (LNTH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Lantheus Holdings Inc Azioni (LNTH) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Blanchfield Paul | Former Officer |
Feb 02 '26 |
Proposed Sale |
66.97 |
6,713 |
449,570 |
0 |
| Blanchfield Paul | Former Officer |
Jan 06 '26 |
Proposed Sale |
69.53 |
7,217 |
501,798 |
0 |
| Blanchfield Paul | Officer |
Dec 12 '25 |
Proposed Sale |
66.82 |
3,265 |
218,151 |
0 |
| Blanchfield Paul | Former Officer |
Nov 26 '25 |
Proposed Sale |
58.31 |
11,776 |
686,665 |
0 |
| Blanchfield Paul | Former Officer |
Nov 14 '25 |
Proposed Sale |
52.70 |
16,530 |
871,106 |
0 |
4.46%
2.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):